WELLS FARGO & COMPANY/MN - MAINZ BIOMED B V ownership

MAINZ BIOMED B V's ticker is and the CUSIP is N5436L101. A total of 7 filers reported holding MAINZ BIOMED B V in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of MAINZ BIOMED B V
ValueSharesWeighting
Q3 2023$584
-75.6%
200
-60.0%
0.00%
Q2 2023$2,390
-23.9%
5000.0%0.00%
Q1 2023$3,140
-1.7%
500
+11.1%
0.00%
Q4 2022$3,1954500.00%
Other shareholders
MAINZ BIOMED B V shareholders Q1 2023
NameSharesValueWeighting ↓
Greenwich Investment Management, Inc. 14,724$136,0000.10%
UBS Group AG 1,364$13,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
CITIGROUP INC 752$7,0000.00%
View complete list of MAINZ BIOMED B V shareholders